secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bionano Genomics, Inc. (BNGO)
CIK:        0001411690
Form:       8-K
Filed at:   2024-12-02T23:59:59+00:00
Accession:  0001411690-24-000066
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Bionano Genomics stockholders approve issuance of up to 35M shares upon warrant exercise
--------------------------------------------------------------------------------

- Vote passed: 22.9M for, 6.2M against, 1.4M abstentions, no broker non-votes.
- Approval covers Series A and B warrants from July 4, 2024 private placement to institutional investors.
- Issuance required for Nasdaq Listing Rule 5635(d) compliance; warrants were already outstanding.
- Potential dilutive impact: up to 35M shares vs. ~86M outstanding as of August 12, 2024 record date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411690/000141169024000066/0001411690-24-000066-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411690/000141169024000066/bngo-20241127.htm
  HTML page:      https://secwatch.observer/filing/0001411690-24-000066

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer